Robert Dickey IV serves as Executive at HEMISPHERX BIOPHARMA INC, where they oversee executive responsibilities. Since joining the company, Robert Dickey IV has executed 6 insider transactions totaling $1.6K, demonstrating a bullish approach to their equity position. Their most recent transaction on Aug 15, 2025 involved receiving (via award) 762 shares valued at $0.
Robert Dickey IV currently holds 762 shares of HEMISPHERX BIOPHARMA INC (HEB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert Dickey IV has been a net buyer of HEB stock. They have purchased $1.6K and sold $0 worth of shares.
Robert Dickey IV's most recent insider trade was on Aug 15, 2025, when they sold 762 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $3.20 |
| Discretionary |
| Aug 1, 2014 | NBS | $0 | Award | 6,303 | $N/A | Discretionary |
| Jun 30, 2014 | NBS | $1.5K | Award | 279 | $5.54 | Discretionary |
| Aug 19, 2013 | NBS | $0 | Award | 5,000 | $N/A | Discretionary |
| Dec 8, 2009 | HEB | $1.6K | Purchase | 2,500 | $0.64 | Discretionary |